In 2018, cross-border M&A activities in life science and healthcare continued to scale up. Europe has become the next popular choice after the US for Chinese pharmaceutical companies to look for technological breakthroughs. China Focus @ Europe Spring, to be held in Vienna on March 27, is going to bring together decision makers from biotech, pharma and investment to foster and facilitate cross-border collaboration.
200+ Attendees
100+ Chinese companies
100+ Assets
10+ European countries
200+ One-to-one meetings
80% Executive Level Attendees
15+ Company Pitch
website: https://events.mybiogate.com/europespring/
register: https://www.eventbrite.com/e/china-focus-europe-spring-registration-53935890701?aff=ebdssbeac
Save €150 by Applying the Promotion Code: Goingpublic2019